Action
JAKs
Alt Name
Olumiant
Approval Jurisdiction
2017 EMA, 2018 FDA
Approved for clinical use
Rheumatoid arthritis
Brutto
C16H17N7O2S
CAS
1187594-09-7
Commercial Vendor
Incyte/Eli Lilly
Compound Image
Baricitinib.png
Compound name
Baricitinib
InChI
InChI=1S/C16H17N7O2S/c1-2-26(24,25)22-9-16(10-22,4-5-17)23-8-12(7-21-23)14-13-3-6-18-15(13)20-11-19-14/h3,6-8,11H,2,4,9-10H2,1H3,(H,18,19,20)
InChI Key
XUZMWHLSFXCVMG-UHFFFAOYSA-N
PubChem CID
44205240
Reference
Reference 2
SMILES
CCS(=O)(=O)N1CC(C1)(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3
Approved Drug List
1